These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27053015)

  • 1. Assessment of inhibition of porcine hepatic cytochrome P450 enzymes by 48 commercial drugs.
    Hu SX; Mazur CA; Feenstra KL; Lorenz JK; Merritt DA
    Vet J; 2016 May; 211():26-31. PubMed ID: 27053015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of
    Hu SX; Mazur CA; Feenstra KL
    Drug Metab Lett; 2019; 13(2):123-131. PubMed ID: 31750810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice.
    Qin CZ; Lv QL; Wu NY; Cheng L; Chu YC; Chu TY; Hu L; Cheng Y; Zhang X; Zhou HH
    J Ethnopharmacol; 2015 Jun; 168():146-9. PubMed ID: 25858508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age on hepatic cytochrome P450 of domestic male Camborough-29 pigs.
    Hu SX
    J Vet Pharmacol Ther; 2015 Apr; 38(2):150-9. PubMed ID: 25230135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
    Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
    Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage stability study of porcine hepatic and intestinal cytochrome P450 isoenzymes by use of a newly developed and fully validated highly sensitive HPLC-MS/MS method.
    Schelstraete W; Devreese M; Croubels S
    Anal Bioanal Chem; 2018 Feb; 410(6):1833-1843. PubMed ID: 29327113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
    Wang B; Yang S; Hu J; Li Y
    J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4'-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study.
    Li Z; Zhang Y; Gao Y; Xiang Y; Zhang W; Lu C; Zhuang X
    Eur J Pharm Sci; 2019 Mar; 130():156-165. PubMed ID: 30690186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytochrome P450 enzymes by saturated and unsaturated fatty acids in human liver microsomes, characterization of enzyme kinetics in the presence of bovine serum albumin (0.1 and 1.0% w/v) and in vitro - in vivo extrapolation of hepatic clearance.
    Palacharla RC; Uthukam V; Manoharan A; Ponnamaneni RK; Padala NP; Boggavarapu RK; Bhyrapuneni G; Ajjala DR; Nirogi R
    Eur J Pharm Sci; 2017 Apr; 101():80-89. PubMed ID: 28179134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes.
    Kuroha M; Kuze Y; Shimoda M; Kokue E
    Am J Vet Res; 2002 Jun; 63(6):900-5. PubMed ID: 12061540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J; Liu Y; Zhang JW; Wei H; Yang L
    Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes.
    Lu Y; Xie T; Zhang Y; Zhou F; Ruan J; Zhu W; Zhu H; Feng Z; Zhou X
    BMC Complement Altern Med; 2017 Jan; 17(1):15. PubMed ID: 28056947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective.
    Schelstraete W; Clerck L; Govaert E; Millecam J; Devreese M; Deforce D; Bocxlaer JV; Croubels S
    Sci Rep; 2019 Jun; 9(1):9233. PubMed ID: 31239454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition.
    Dahlinger D; Duechting S; Nuecken D; Sydow K; Fuhr U; Frechen S
    J Pharmacol Toxicol Methods; 2016; 77():66-75. PubMed ID: 26528794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay.
    Pandit S; Kanjilal S; Awasthi A; Chaudhary A; Banerjee D; Bhatt BN; Narwaria A; Singh R; Dutta K; Jaggi M; Singh AT; Sharma N; Katiyar CK
    J Ethnopharmacol; 2017 Feb; 197():165-172. PubMed ID: 27457692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.
    Chatterjee P; Franklin MR
    Drug Metab Dispos; 2003 Nov; 31(11):1391-7. PubMed ID: 14570772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.